Following the initial impact of the COVID-19 pandemic, the Japanese market for vascular access devices will decline through 2029, limited by strong pricing pressures and continued efforts to…
Following the initial impact of the COVID-19 pandemic, the European market for aortic repair devices will expand at a modest rate through 2029, driven primarily by endovascular procedure…
The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure…
Despite a changing and challenging reimbursement landscape, the US market for orthotic devices will continue to grow at a modest rate through 2027, primarily driven by favorable demographics,…
The global market for hypertension management devices consists of devices that represent a novel form of treatment for patients with uncontrolled hypertension. Given the unmet clinical need for…
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…
The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the…
The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the…
The global market for outsourced medical devices will expand moderately through 2027. Although ongoing pressure to reduce production expenses will drive many brand owners to partner with…
The US drug delivery device market will grow moderately through 2027, fueled by growth in patient populations and the approval of biosimilars for drug delivery devices. The opportunities…
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…
The US varicose vein treatment device market will be characterized by modest growth and a changing reimbursement landscape for new endovenous ablation technologies, which will compete with more…
The Asia Pacific CMF device market differs significantly from the US and Europe CMF spaces due to a number of factors, including the wide range of domestic product options available and the…
The mature European CABG device market will contract modestly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in …
The mature US CABG device market will contract slightly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in off-pump and…